Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	111.53	364.17	172.16
Graham Fair Price	-61.49	3.47	9.00
PEG	654.35	-2.14	0.28
Price/Book	14.77	15.75	13.73
Price/Cash Flow	232.97	494.15	148.40
Prices/Earnings	655.30	181.72	24.06
Price/Sales	37.16	76.37	55.68
Price/FCF	232.97	494.15	148.40
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-3.92	0.62	0.64
Operating Margin	-49.25	0.13	0.26
ROA	-84.55	0.02	0.12
ROE	0.14	0.02	-84.80
ROIC	0.13	0.02	-83.86
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.22	0.35	-37.69
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.23	-0.58	-148.91
EPS QOQ	0.85	-0.85	0.13
FCF QOQ	-0.18	-0.66	-273.76
Revenue QOQ	-0.11	-0.17	-55.50
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	146.28	159.75	9.21
Days Sales Outstanding (DSO)	60.97	63.24	3.72
Inventory Turnover	0.62	0.56	-8.43
Debt/Capitalization	0.02	0.03	16.78
Quick Ratio	2.50	2.53	1.07
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	5.03	4.97	-1.20
Cash	0.93	0.78	-16.12
Capex	-0.06	-0.06	2.56
Free Cash Flow	0.46	0.16	-65.95
Revenue	1.24	1.02	-17.33
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	3.78	4.18	10.59
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-2.05	-3.23	-57.43
Naive Interpretation	Member

06 - Financial Health · Bad

Rating